Nanocarriers as an emerging platform for cancer therapy
Top Cited Papers
- 1 December 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Nanotechnology
- Vol. 2 (12), 751-760
- https://doi.org/10.1038/nnano.2007.387
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancerBreast Cancer Research and Treatment, 2007
- Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1Proceedings of the National Academy of Sciences of the United States of America, 2007
- Facile Synthesis of Gold−Silver Nanocages with Controllable Pores on the SurfaceJournal of the American Chemical Society, 2006
- Polymer conjugates as anticancer nanomedicinesNature Reviews Cancer, 2006
- Immunotoxin therapy of cancerNature Reviews Cancer, 2006
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProceedings of the National Academy of Sciences of the United States of America, 2006
- Metal NanoshellsAnnals of Biomedical Engineering, 2006
- Targeting of RGD‐modified proteins to tumor vasculature: A pharmacokinetic and cellular distribution studyInternational Journal of Cancer, 2002
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Attempted targeting of a monoclonal antibody in a human tumour xenograft systemEuropean Journal of Cancer and Clinical Oncology, 1981